Published in Clin Gastroenterol Hepatol on January 01, 2007
Investigation of Sexual Function in Crohn's Disease Patients With Perianal Fistulas | NCT01635543
Sexual function and patients' perceptions in inflammatory bowel disease: a case-control survey. J Gastroenterol (2012) 1.14
Endocrine and metabolic manifestations in inflammatory bowel disease. Ann Gastroenterol (2012) 0.93
Inflammatory bowel diseases and human reproduction: a comprehensive evidence-based review. World J Gastroenterol (2014) 0.85
Determinants of female sexual function in inflammatory bowel disease: a survey based cross-sectional analysis. BMC Gastroenterol (2008) 0.85
Quality of life in patients with ulcerative colitis treated surgically. Prz Gastroenterol (2014) 0.81
Optimizing the Care and Health of Women with Inflammatory Bowel Disease. Gastroenterol Res Pract (2015) 0.81
Inflammatory bowel disease and sexual dysfunction. Gastroenterol Hepatol (N Y) (2014) 0.79
Getting personal: a review of sexual functioning, body image, and their impact on quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis (2015) 0.77
Therapy of complicated Crohn's disease during pregnancy--an interdisciplinary challenge. Int J Colorectal Dis (2014) 0.76
Sexuality and elderly with chronic diseases: A review of the existing literature. J Res Med Sci (2016) 0.75
Infertility in men with inflammatory bowel disease. World J Gastrointest Pharmacol Ther (2016) 0.75
Pregnancy and inflammatory bowel diseases: Current perspectives, risks and patient management. World J Gastrointest Pharmacol Ther (2015) 0.75
The Emerging Adult with Inflammatory Bowel Disease: Challenges and Recommendations for the Adult Gastroenterologist. Gastroenterol Res Pract (2015) 0.75
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis. J Crohns Colitis (2010) 3.97
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations. J Crohns Colitis (2009) 3.66
Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis (2007) 2.89
Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis. Proc Natl Acad Sci U S A (2006) 2.31
Diagnostic delay in Crohn's disease is associated with a complicated disease course and increased operation rate. Am J Gastroenterol (2013) 2.05
[Meulengracht disease]. Praxis (Bern 1994) (2013) 2.00
Interleukin-10 blocked endoplasmic reticulum stress in intestinal epithelial cells: impact on chronic inflammation. Gastroenterology (2006) 1.93
Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity. PLoS One (2007) 1.86
Cell-cell contacts prevent anoikis in primary human colonic epithelial cells. Gastroenterology (2006) 1.84
Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation. Blood (2004) 1.76
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis (2012) 1.71
Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol (2010) 1.69
Evidence for a role of epithelial mesenchymal transition during pathogenesis of fistulae in Crohn's disease. Inflamm Bowel Dis (2008) 1.61
Multiparameter immunofluorescence on paraffin-embedded tissue sections. Appl Immunohistochem Mol Morphol (2006) 1.59
Association of antibodies to exocrine pancreas with subtypes of Crohn's disease. Eur J Gastroenterol Hepatol (2005) 1.53
Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines. J Pediatr Gastroenterol Nutr (2012) 1.52
Prostaglandin E2 inhibits migration of colonic lamina propria fibroblasts. Inflamm Bowel Dis (2010) 1.47
Epithelial-to-mesenchymal transition in a fistula-associated anal adenocarcinoma in a patient with long-standing Crohn's disease. Eur J Gastroenterol Hepatol (2014) 1.46
European evidenced-based consensus on reproduction in inflammatory bowel disease. J Crohns Colitis (2010) 1.45
Determinants of male sexual function in inflammatory bowel disease: a survey-based cross-sectional analysis in 280 men. Inflamm Bowel Dis (2007) 1.45
Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease. Inflamm Bowel Dis (2011) 1.41
European evidence-based Consensus on the management of ulcerative colitis: Special situations. J Crohns Colitis (2008) 1.34
Comparison of capsule endoscopy and magnetic resonance (MR) enteroclysis in suspected small bowel disease. Int J Colorectal Dis (2005) 1.28
Diagnosis and management of fistulizing Crohn's disease. Nat Clin Pract Gastroenterol Hepatol (2009) 1.25
CpG motifs of bacterial DNA essentially contribute to the perpetuation of chronic intestinal inflammation. Gastroenterology (2005) 1.25
Colitis-associated colon tumorigenesis is suppressed in transgenic mice rich in endogenous n-3 fatty acids. Carcinogenesis (2007) 1.23
Extraintestinal Manifestations of Inflammatory Bowel Disease. Inflamm Bowel Dis (2015) 1.21
Profiling adipocytokine secretion from creeping fat in Crohn's disease. Inflamm Bowel Dis (2006) 1.15
Smoking cessation induces profound changes in the composition of the intestinal microbiota in humans. PLoS One (2013) 1.15
Differential protein expression profile in the intestinal epithelium from patients with inflammatory bowel disease. J Proteome Res (2007) 1.13
Effects of systemic administration of a local anesthetic on pain in acute pancreatitis: a randomized clinical trial. Pancreas (2011) 1.12
Orofacial granulomatosis as the initial presentation of Crohn's disease in an adolescent. Dermatology (2003) 1.12
Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohn's disease. Inflamm Bowel Dis (2010) 1.11
Transforming growth factor-beta 1 induces intestinal myofibroblast differentiation and modulates their migration. World J Gastroenterol (2009) 1.07
Epidermal growth factor partially restores colonic ion transport responses in mouse models of chronic colitis. Gastroenterology (2005) 1.07
Modern imaging using computer tomography and magnetic resonance imaging for inflammatory bowel disease (IBD) AU1. Inflamm Bowel Dis (2004) 1.07
Abdominal MRI after enteroclysis or with oral contrast in patients with suspected or proven Crohn's disease. Clin Gastroenterol Hepatol (2004) 1.07
13-Oxo-ODE is an endogenous ligand for PPARgamma in human colonic epithelial cells. Biochem Pharmacol (2007) 1.06
Serum anti-glycan antibodies predict complicated Crohn's disease behavior: a cohort study. Inflamm Bowel Dis (2010) 1.04
Protection of epithelial barrier function by the Crohn's disease associated gene protein tyrosine phosphatase n2. Gastroenterology (2009) 1.04
Systematic assessment of factors influencing preferences of Crohn's disease patients in selecting an anti-tumor necrosis factor agent (CHOOSE TNF TRIAL). Inflamm Bowel Dis (2011) 1.04
Association of the novel serologic anti-glycan antibodies anti-laminarin and anti-chitin with complicated Crohn's disease behavior. Inflamm Bowel Dis (2010) 1.03
Reduced migration of fibroblasts in inflammatory bowel disease: role of inflammatory mediators and focal adhesion kinase. Gastroenterology (2003) 1.02
Impact of pain on health-related quality of life in patients with inflammatory bowel disease. World J Gastroenterol (2010) 1.01
Serum soluble TNF receptor I and II levels correlate with disease activity in IBD patients. Inflamm Bowel Dis (2007) 1.01
European evidence based consensus on surgery for ulcerative colitis. J Crohns Colitis (2015) 1.01
Improvement of arthritis and arthralgia after treatment with infliximab (Remicade) in a German prospective, open-label, multicenter trial in refractory Crohn's disease. Am J Gastroenterol (2002) 1.00
Severe Sweet's Syndrome with Elevated Cutaneous Interleukin-1β after Azathioprine Exposure: Case Report and Review of the Literature. Dermatology (2015) 0.98
Galectin-4 controls intestinal inflammation by selective regulation of peripheral and mucosal T cell apoptosis and cell cycle. PLoS One (2008) 0.97
Frequency and nature of incidental extra-enteric lesions found on magnetic resonance enterography (MR-E) in patients with inflammatory bowel diseases (IBD). PLoS One (2009) 0.97
Functional expression of the interleukin-11 receptor alpha-chain and evidence of antiapoptotic effects in human colonic epithelial cells. J Biol Chem (2003) 0.96
Ephrin-B2 is differentially expressed in the intestinal epithelium in Crohn's disease and contributes to accelerated epithelial wound healing in vitro. World J Gastroenterol (2005) 0.96
Human colonic myofibroblasts promote expansion of CD4+ CD25high Foxp3+ regulatory T cells. Gastroenterology (2011) 0.96
Expression of growth factor receptors and targeting of EGFR in cholangiocarcinoma cell lines. BMC Cancer (2010) 0.96
Inverse regulation of the ADAM-family members, decysin and MADDAM/ADAM19 during monocyte differentiation. Immunology (2003) 0.95
Magnetization transfer for the assessment of bowel fibrosis in patients with Crohn's disease: initial experience. MAGMA (2012) 0.94
Stimulation of human colonic epithelial cells by leukemia inhibitory factor is dependent on collagen-embedded fibroblasts in organotypic culture. FASEB J (2003) 0.94
The c.1-260C>T promoter variant of CD14 but not the c.896A>G (p.D299G) variant of toll-like receptor 4 (TLR4) genes is associated with inflammatory bowel disease. Digestion (2007) 0.94
Loss of protein tyrosine phosphatase nonreceptor type 22 regulates interferon-γ-induced signaling in human monocytes. Gastroenterology (2013) 0.93
Inflammatory bowel disease pathogenesis: what is new? Curr Opin Gastroenterol (2012) 0.93
Progress on isolation and short-term ex-vivo culture of highly purified non-apoptotic human intestinal epithelial cells (IEC). Eur J Cell Biol (2003) 0.93
Smoking cessation alters intestinal microbiota: insights from quantitative investigations on human fecal samples using FISH. Inflamm Bowel Dis (2014) 0.92
Protein tyrosine phosphatase nonreceptor type 2 regulates autophagosome formation in human intestinal cells. Inflamm Bowel Dis (2011) 0.92
Autocrine fibronectin-induced migration of human colonic fibroblasts. Am J Gastroenterol (2004) 0.92
Psychosocial distress in acute cancer patients assessed with an expert rating scale. Support Care Cancer (2010) 0.92
Interleukin-13 and transforming growth factor β synergise in the pathogenesis of human intestinal fistulae. Gut (2012) 0.92
First-line therapies in inflammatory bowel disease. Digestion (2012) 0.91
Genetic variants in the NOD2/CARD15 gene are associated with early mortality in sepsis patients. Intensive Care Med (2007) 0.91
The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study. Eur J Gastroenterol Hepatol (2008) 0.91
Genetic susceptibility to increased bacterial translocation influences the response to biological therapy in patients with Crohn's disease. Gut (2013) 0.90
Potential role for SNAIL family transcription factors in the etiology of Crohn's disease-associated fistulae. Inflamm Bowel Dis (2010) 0.90
Use of thiopurines in inflammatory bowel disease. World J Gastroenterol (2013) 0.89
Dying in yoghurt: the number of living bacteria in probiotic yoghurt decreases under exposure to room temperature. Digestion (2010) 0.89
Association of perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies with Vienna classification subtypes of Crohn's disease. Inflamm Bowel Dis (2003) 0.89
The intestinal microbiota: its role in health and disease. Eur J Pediatr (2015) 0.88
New insights into the pathogenesis of Crohn's disease: are they relevant for therapeutic options? Swiss Med Wkly (2009) 0.88
Bile salt-induced apoptosis in human colon cancer cell lines involves the mitochondrial transmembrane potential but not the CD95 (Fas/Apo-1) receptor. Int J Colorectal Dis (2004) 0.88
Crohn's disease-associated polymorphism within the PTPN2 gene affects muramyl-dipeptide-induced cytokine secretion and autophagy. Inflamm Bowel Dis (2011) 0.88
Sphingomyelin induces cathepsin D-mediated apoptosis in intestinal epithelial cells and increases inflammation in DSS colitis. Gut (2010) 0.88
Strong expression of methylthioadenosine phosphorylase (MTAP) in human colon carcinoma cells is regulated by TCF1/[beta]-catenin. Lab Invest (2005) 0.88
Milk oligosaccharide sialyl(α2,3)lactose activates intestinal CD11c+ cells through TLR4. Proc Natl Acad Sci U S A (2013) 0.88
IL-15 protects intestinal epithelial cells. Eur J Immunol (2006) 0.88
Inflammatory bowel disease: dysfunction of autophagy? Dig Dis (2013) 0.87
Open label trial of granulocyte apheresis suggests therapeutic efficacy in chronically active steroid refractory ulcerative colitis. World J Gastroenterol (2005) 0.87
Characterization of changes in serum anti-glycan antibodies in Crohn's disease--a longitudinal analysis. PLoS One (2011) 0.87
Recent advances using immunomodulators for inflammatory bowel disease. J Clin Pharmacol (2013) 0.87
A case of recurrent gastrointestinal bleeding and protein-losing gastroenteropathy. Nat Clin Pract Gastroenterol Hepatol (2007) 0.87
Optimising the diagnostic value of anti-Saccharomyces cerevisiae-antibodies (ASCA) in Crohn's disease. Int J Colorectal Dis (2004) 0.87
Vascular endothelial growth factor secretion from mesenteric adipose tissue and from creeping fat in Crohn's disease. J Gastroenterol Hepatol (2006) 0.87
Protein tyrosine phosphatase N2 regulates TNFα-induced signalling and cytokine secretion in human intestinal epithelial cells. Gut (2010) 0.87
BCL-2 modifying factor (BMF) is a central regulator of anoikis in human intestinal epithelial cells. J Biol Chem (2011) 0.86
Prevalence of anaemia in inflammatory bowel disease in Switzerland: a cross-sectional study in patients from private practices and university hospitals. J Crohns Colitis (2010) 0.86
Enteral and parenteral nutrition distinctively modulate intestinal permeability and T cell function in vitro. Eur J Nutr (2008) 0.86
The role of helix 8 and of the cytosolic C-termini in the internalization and signal transduction of B(1) and B(2) bradykinin receptors. FEBS J (2005) 0.86
Recipient NOD2/CARD15 variants: a novel independent risk factor for the development of bronchiolitis obliterans after allogeneic stem cell transplantation. Biol Blood Marrow Transplant (2008) 0.86